Abstract-Accumulating evidence shows an increase in insulin resistance on salt restriction. We compared the effect of low salt diet on insulin resistance in salt-sensitive versus salt-resistant hypertensive subjects. We also evaluated the relationship between salt sensitivity of blood pressure and salt sensitivity of insulin resistance in a multivariate regression model. Studies were conducted after 1 week of high salt (200 mmol per day sodium) and 1 week of low salt (10 mmol per day sodium) diet. Salt sensitivity was defined as the fall in systolic blood pressure >15 mm Hg on low salt diet. The study includes 389 subjects (44% women; 16% blacks; body mass index, 28.5±4.2 kg/m 2 ). As expected, blood pressure was lower on low salt (129±16/78±9 mm Hg) as compared with high salt diet (145±18/86±10 mm Hg). Fasting plasma glucose, insulin, and homeostasis model assessment were higher on low salt diet (95.4±19.4 mg/dL; 10.8±7.3 mIU/L; 2.6±1.9) as compared with high salt diet (90.6±10.8 mg/dL; 9.4±5.8 mIU/L; 2.1±1.4; P<0.0001 for all). There was no difference in homeostasis model assessment between salt-sensitive (n=193) versus salt-resistant (n=196) subjects on either diet. Increase in homeostasis model assessment on low salt diet was 0.5±1.4 in salt-sensitive and 0.4±1.5 in saltresistant subjects (P=NS). On multivariate regression analysis, change in systolic blood pressure was not associated with change in homeostasis model assessment after including age, body mass index, sex, change in serum and urine aldosterone, and cortisol into the model. We conclude that the increase in insulin resistance on low salt diet is not affected by salt sensitivity of blood pressure. (Hypertension. 2014;64:1384-1387.)
L ow salt (LS) intake is recommended as a public health measure to decrease the risk of cardiovascular disease (CVD). 1 Much of this risk reduction is attributable to reduction in blood pressure observed in most individuals who reduce salt intake. 1, 2 However, recent studies have suggested increased mortality in association with LS intake. [3] [4] [5] Although the reason for this increased mortality is not fully understood, physiologically, LS intake stimulates the renin-angiotensin-aldosterone system (RAAS), which may contribute to the increased risk of CVD. 6 We have shown an association between increased aldosterone production and insulin resistance (IR) in normotensive healthy subjects and in overweight subjects. 7, 8 Furthermore, we have demonstrated that LS diet increases IR in healthy subjects. 9 Similar observations have been made in hypertensive subjects. 10, 11 The overall impact of LS diet in hypertensive subjects is likely to depend on salt sensitivity. Individuals whose blood pressure is sensitive to salt intake have higher RAAS activity on liberal salt diet. 12 They also have higher IR and higher chances of having metabolic syndrome as compared with salt-resistant hypertensive individuals. 12, 13 Some experts have suggested salt restriction as a method of reversing or controlling the metabolic syndrome in salt-sensitive individuals. 14, 15 Activation of RAAS in response to LS diet is less prominent in salt-sensitive individuals, and, therefore, salt restriction should not cause much of an increase in IR in these individuals. [16] [17] [18] On the contrary, LS diet significantly activates RAAS in saltresistant individuals and may increase IR in these individuals. 18 We hypothesized that the increase in IR on LS diet is lower in salt-sensitive hypertension than in salt-resistant hypertension. In this study, we compared the increase in homeostasis model assessment (HOMA) in response to LS diet in salt-sensitive versus salt-resistant hypertensive subjects. We also evaluated whether there is an association between salt sensitivity of blood pressure and salt sensitivity of IR in the hypertensive population.
Methods
This post hoc data analysis includes hypertensive subjects studied under both high and low dietary salt intake conditions in several common research protocols at our institute during the time period from 1992 to 2012. 17, [19] [20] [21] [22] The protocols were approved by the institutional review board, and all subjects signed an informed consent. Subjects required a screening blood pressure >140/90 mm Hg or were taking antihypertensive medications to be included in this study. All participants underwent a screening history, physical examination, and laboratory tests. Those with a history of diabetes mellitus, coronary artery disease, stroke, current tobacco use, illicit drug use, or alcohol intake >12 ounces per week, or any other significant medical or psychiatric illness were excluded. Those with abnormal baseline values of serum electrolytes, serum creatinine, thyroid or liver function tests, or electrocardiographic evidence of heart block, ischemia, or prior coronary events were also excluded.
All antihypertensive medications except for calcium channel blockers were held for 3 months before dietary studies were performed. Participants were provided high salt (HS) and LS diets, each for 7 days with at least 1 week washout period in-between. HS diet included 200 mmol per day sodium, 100 mmol per day potassium, 20 mmol per day calcium, and no caffeine or alcohol. This diet approximates the sodium intake of the general US population. LS diet consisted of 10 mmol per day sodium and all other components equivalent to the HS diet. The subjects were allowed to drink water ad lib. The diets were provided by the research kitchen, but subjects were allowed to take it home.
On the morning of the sixth day of each diet, participants began a 24-hour urine collection for assessment of sodium, creatinine, aldosterone, and cortisol. High sodium balance was defined as a urinary sodium >150 mmol/24 hours, and low sodium balance was defined as urinary sodium <30 mmol/24 hours on respective diets. Subjects were admitted to the inpatient clinical research center for detailed studies. After the evening meal, participants remained fasting and supine overnight for 8 to 10 hours, and hemodynamic and laboratory assessments were made the following morning before 10.00 am. Blood pressure was measured at 5-minute intervals using an automated device (Dinamap; Critikon, Tampa, FL); 5 consecutive readings were averaged for analysis. A fasting blood sample was obtained for measurement of glucose, insulin, plasma renin activity, aldosterone, cortisol, sodium, and potassium. All laboratory assays were performed at a central core laboratory.
Statistical Analysis
The HOMA was used as an index of IR and calculated as HOMA=(plasma glucose (mg/dL)×plasma insulin (μU/mL))/405. 23 Salt sensitivity was defined as the fall in systolic blood pressure >15 mm Hg on LS diet as compared with HS diet. Non-normally distributed data were natural-logarithmically transformed before analysis with parametric statistical methods. Comparisons between HS and LS diets were made in the overall group and in subgroups of saltsensitive and salt-resistant hypertension. Paired t tests were used to examine differences between the 2 diets within groups. Correlations between the change in IR from HS to LS diet and changes in other variables including blood pressure and hormone levels were derived using Pearson correlation coefficient. Those with P<0.1 or known to affect IR were included in the multivariate regression model. All data are shown as mean with SD unless specified. The statistical analyses were performed using the SAS 9.1 statistical software package (SAS Institute Inc, Cary, NC).
Results
A total of 389 subjects with hypertension were included in the final analysis based on availability of the analyzed data points. Differences in clinical and biochemical variables on HS diet versus LS diet in the overall group are shown in Table 1 . As expected, blood pressure was lower on LS diet with a consequently activated RAAS. Fasting plasma glucose, insulin, and HOMA were significantly higher while on LS diet as compared with HS diet.
Based on systolic blood pressure change of >15 mm Hg, 193 subjects were classified as salt-sensitive (age, 50.3±7.5 years; 49% women; 16% black) and 196 subjects were classified as salt-resistant (age, 47.8±8.5 years; 38% women; 16% black). Both populations had a significant increase in HOMA on LS diet as compared with HS diet (Table 2 ). There was no difference in baseline HOMA on HS diet between the 2 populations. The increase in HOMA on LS diet was also similar in salt-sensitive and salt-resistant groups.
Univariate regression analyses did not find an association between the change in HOMA and the change in systolic blood pressure. In a multivariable regression model that included all the potential modulators of IR, change in HOMA was not significantly associated with any other clinical or biochemical variables (Table 3) .
Discussion
This study demonstrates that 1 week of LS diet increases IR equally in both salt-sensitive and salt-resistant hypertensive individuals, and that salt sensitivity of blood pressure does not modify the relationship between IR and salt restriction. Thus, salt restriction in salt-resistant individuals seems to offer no advantage (little effect on blood pressure and elevation in IR). This conclusion is similar to one drawn by Laffer et al 24 using a different protocol to determine salt sensitivity and IR. Individuals with salt-sensitive hypertension that make a substantial portion (≈50%) of the hypertensive population would receive the blood pressure-lowering benefit from salt restriction, but it would be accompanied by an increase in IR. It is important to point out the difficulty in gauging the net risk/ benefit of these 2 factors, and that this study does not address the overall outcomes of a salt-restricted diet.
Observational studies have assumed that the blood pressurelowering effects of salt restriction will translate into a reduction in CVD. 2 Recent studies showing increased mortality in association with LS intake, especially in patients with diabetes mellitus, question these assumptions. [3] [4] [5] Although salt sensitivity was not evaluated in those studies, patients with diabetes mellitus in general are known to have increased salt sensitivity. 25, 26 Whether there can be dissociation between IR on LS diet and risk of CVD will need to be determined in future studies. Just as the harmful effect of aldosterone depends on HS conditions and there is dissociation between the levels of aldosterone and its vascular effects on LS diet, effect of IR may also depend on salt loading conditions, and there may be dissociation between IR and its cardiovascular effects. We think more work is needed to investigate the downstream effects of increase in IR under LS conditions and its implications in disease states. 
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Our results are consistent with existing data showing an increase in IR on salt restriction in normotensive and hypertensive subjects. 9, 11, 27 However, to our surprise, the increase in IR was neither predicted by change in blood pressure nor by any other clinical or biochemical parameters. Basic and clinical research has shown a relation between RAAS activity and IR. 7, 28 Because of RAAS activation under LS diet conditions, we considered this to be the underlying mechanism for increase in IR on LS diet. However, in this study, we did not find a relation between increase in RAAS activity and increase in IR. This suggests that RAAS activity is probably not a mediator of increase in IR on LS diet. Other unmeasured factors may have contributed to increase in IR, or salt restriction may have a direct effect on insulin-signaling mechanisms.
We did not find a difference in baseline IR between salt-sensitive and salt-resistant subjects on either HS or LS diet. Studies demonstrating higher IR on HS diet in salt-sensitive individuals used other methods of measuring IR, such as glucose tolerance test or euglycemic clamp studies. [29] [30] [31] [32] A difference in fasting glucose and insulin levels at baseline has not been described. Using another measure of IR may have changed the results of our study. However, we think our data are relevant because of a large sample size and meticulously controlled conditions. The limited duration (1 week) and lower-than-recommended saltrestricted diet provide additional limitations to consider. Our 10 mmol per day sodium diet is made of ordinary food products obtainable in most grocery stores and contains a wide variety of fruits, vegetables, grains, and meats. This 10 mmol per day sodium diet is routinely used to stimulate the RAAS to conduct dynamic endocrine research studies. However, 10 mmol per day sodium is at the extreme lower end of the physiological range of sodium intakes and not practical for long-term use. It is possible that the degree of salt restriction correlates with the degree of IR, thus resulting in observations that might seem more striking than in nonexperimental physiological salt-restricted environments. However, the impact would be expected to be clinically significant across a spectrum of salt restriction.
In conclusion, salt restriction for 1 week increases IR in hypertensive subjects, and this effect is not modified by salt sensitivity of blood pressure. The clinical importance of an increase in IR with long-term salt restriction needs to be further explored to more precisely and confidently establish broad-based recommendations for salt restriction in the hypertensive population.
Perspectives
Salt restriction is emphasized for the hypertensive population as part of a healthy lifestyle. The rationale for salt restriction is lower blood pressure that should improve cardiovascular outcomes. However, salt restriction has no significant effect on blood pressure in salt-resistant individuals and is associated with increase in IR in both salt-sensitive and salt-resistant individuals. Although the importance of increase in IR in the setting of LS diet is not known, IR in other settings is an established CVD risk factor. Therefore, salt restriction in salt-resistant individuals seems to offer no advantage, whereas its benefits in salt-sensitive individuals need to be considered in the context of increase in IR.
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